Skip to main content
Log in

A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety

  • MULTIMEDIA REPORT
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

Stress and anxiety are potential consequences from arrhythmias and implantable cardioverter defibrillator (ICD) shocks that can contribute to substantial morbidity. We assessed anxiety associated with an ICD and whether cognitive behavioral therapy (CBT) reduces anxiety.

Methods

The study consisted of two parts: part 1 (N = 690) was a prospective cross-sectional observational study of consecutive ICD patients. Patients completed the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder Scale (GAD-7), Florida Shock Anxiety Scale (FSAS), and Florida Patient Acceptance Survey (FPAS) psychometric tests. Part 2 (N = 29) was a pilot randomized controlled trial of CBT (three sessions in 3 months) vs. usual care (UC) in patients with BAI ≥ 19 from part 1.

Results

The median BAI and GAD-7 scores were 5 and 2, respectively. By BAI scores, 64.5 % had minimal and 3.9 % had severe anxiety. By GAD-7 scores, 73.0 % had low probability of anxiety and 2.9 % had high anxiety. Higher anxiety levels were associated with recent (p = 0.017) and total number of shocks (p = 0.002). Any shock was associated with fear about shocks (FSAS, p < 0.001) and reduced patient ICD acceptance (FPAS, p = 0.019). In the pilot trial of CBT, median BAI scores decreased from 24.5 to 11 at 1 year (p = 0.031) in the CBT group and GAD-7 scores from 12.5 to 7 (p = 0.063); no significant changes in anxiety scores were observed in the UC group.

Conclusions

Severe anxiety was present in a small proportion of ICD patients, but higher anxiety was associated with recent and total number of shocks. The small pilot study suggested that a simple program of CBT might lower moderate-high anxiety with lasting effects to 1 year and supports the need for a larger trial to validate these results.

Clinical Trial Registration: ClinicalTrials.gov identifier: NCT00851071.

URL: http://clinicaltrials.gov/ct2/show/NCT00851071?term=anxiety+in+icd+patients+cleveland+clinic&rank=1

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CBT:

Cognitive behavioral therapy

UC:

Usual care

ICD:

Implantable cardioverter defibrillator

References

  1. Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. New England Journal of Medicine, 359(10), 1009–1017.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Schluter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47(3), 459–463.

    CAS  PubMed  Google Scholar 

  3. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237.

    Article  CAS  PubMed  Google Scholar 

  4. Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–1890.

    Article  CAS  PubMed  Google Scholar 

  5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997). New England Journal of Medicine, 337(22), 1576–1583.

  6. Hallas, C. N., Burke, J. L., White, D. G., & Connelly, D. T. (2010). A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery. Circulation. Arrhythmia and Electrophysiology, 3(2), 170–177.

    Article  PubMed  Google Scholar 

  7. van den Broek, K. C., Nyklicek, I., & Denollet, J. (2009). Anxiety predicts poor perceived health in patients with an implantable defibrillator. Psychosomatics, 50(5), 483–492.

    Article  PubMed  Google Scholar 

  8. Sears, S. F., Jr., Todaro, J. F., Lewis, T. S., Sotile, W., & Conti, J. B. (1999). Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clinical Cardiology, 22(7), 481–489.

    Article  PubMed  Google Scholar 

  9. Bilge, A. K., Ozben, B., Demircan, S., Cinar, M., Yilmaz, E., & Adalet, K. (2006). Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing and Clinical Electrophysiology, 29(6), 619–626.

    Article  PubMed  Google Scholar 

  10. Burg, M. M., Lampert, R., Joska, T., Batsford, W., & Jain, D. (2004). Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosomatic Medicine, 66(6), 898–902.

    Article  PubMed  Google Scholar 

  11. Lampert, R., Joska, T., Burg, M. M., Batsford, W. P., McPherson, C. A., & Jain, D. (2002). Emotional and physical precipitants of ventricular arrhythmia. Circulation, 106(14), 1800–1805.

    Article  PubMed  Google Scholar 

  12. Hegel, M. T., Griegel, L. E., Black, C., Goulden, L., & Ozahowski, T. (1997). Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. International Journal of Psychiatry in Medicine, 27(1), 57–69.

    Article  CAS  PubMed  Google Scholar 

  13. Aronow, W. S. (2010). Use of implantable cardioverter-defibrillators. Future Cardiology, 6(6), 859–870.

    Article  PubMed  Google Scholar 

  14. Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K. H., Zipes, D. P., et al. (2000). Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. European Heart Journal, 21(24), 2071–2078.

    Article  CAS  PubMed  Google Scholar 

  15. Ingles, J., Sarina, T., Kasparian, N., & Semsarian, C. (2013). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology. 168(4), 3779–3784.

  16. Freedenberg, V., Thomas, S. A., & Friedmann, E. (2011). Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Failure Clinic, 7(1), 59–68.

    Article  Google Scholar 

  17. Chevalier, P., Cottraux, J., Mollard, E., Sai, N., Brun, S., Burri, H., et al. (2006). Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. American Heart Journal, 151(1), 191.

    Article  PubMed  Google Scholar 

  18. Fitchet, A., Doherty, P. J., Bundy, C., Bell, W., Fitzpatrick, A. P., & Garratt, C. J. (2003). Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart, 89(2), 155–160.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Lewin, R. J., Coulton, S., Frizelle, D. J., Kaye, G., & Cox, H. (2009). A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart, 95(1), 63–69.

    Article  CAS  PubMed  Google Scholar 

  20. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.

    Article  CAS  PubMed  Google Scholar 

  21. Julian, L. J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Research (Hoboken), 63(Suppl 11), S467–S472.

    Article  Google Scholar 

  22. Kertz, S., Bigda-Peyton, J., & Bjorgvinsson, T. (2012). Validity of the Generalized Anxiety Disorder-7 Scale in an Acute Psychiatric Sample. Clinical Psychology & Psychotherapy. 20(5), 456–464.

  23. Kuhl, E. A., Dixit, N. K., Walker, R. L., Conti, J. B., & Sears, S. F. (2006). Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology, 29(6), 614–618.

    Article  PubMed  Google Scholar 

  24. Burns, J. L., Serber, E. R., Keim, S., & Sears, S. F. (2005). Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. Journal of Cardiovascular Electrophysiology, 16(4), 384–390.

    Article  PubMed  Google Scholar 

  25. Habibovic, M., Versteeg, H., Pelle, A. J., Theuns, D. A., Jordaens, L., & Pedersen, S. S. (2013). Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace, 15(3), 355–361.

    Article  PubMed  Google Scholar 

  26. Magyar-Russell, G., Thombs, B. D., Cai, J. X., Baveja, T., Kuhl, E. A., Singh, P. P., et al. (2011). The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. Journal of Psychosomatic Research, 71(4), 223–231.

    Article  PubMed  Google Scholar 

  27. Godemann, F., Butter, C., Lampe, F., Linden, M., Schlegl, M., Schultheiss, H. P., et al. (2004). Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clinical Cardiology, 27(6), 321–326.

    Article  PubMed  Google Scholar 

  28. Jacq, F., Foulldrin, G., Savoure, A., Anselme, F., Baguelin-Pinaud, A., Cribier, A., et al. (2009). A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. General Hospital Psychiatry, 31(3), 266–273.

    Article  PubMed  Google Scholar 

  29. Van den Broek, K. C., Nyklicek, I., Van der Voort, P. H., Alings, M., & Denollet, J. (2008). Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing and Clinical Electrophysiology, 31(7), 850–857.

    Article  PubMed  Google Scholar 

  30. Chevalier, P., Verrier, P., Kirkorian, G., Touboul, P., & Cottraux, J. (1996). Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator: a psychometric study. Psychotherapy and Psychosomatics, 65(1), 49–56.

    Article  CAS  PubMed  Google Scholar 

  31. Dunbar, S. B., Langberg, J. J., Reilly, C. M., Viswanathan, B., McCarty, F., Culler, S. D., et al. (2009). Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing and Clinical Electrophysiology, 32(10), 1259–1271.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Redhead, A. P., Turkington, D., Rao, S., Tynan, M. M., & Bourke, J. P. (2010). Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research, 69(6), 555–563.

    Article  PubMed  Google Scholar 

  33. Pedersen, S. S., Sears, S. F., Burg, M. M., & Van Den Broek, K. C. (2009). Does ICD indication affect quality of life and levels of distress? Pacing and Clinical Electrophysiology, 32(2), 153–156.

    Article  PubMed  Google Scholar 

  34. Sears, S. F., Sowell, L. D., Kuhl, E. A., Kovacs, A. H., Serber, E. R., Handberg, E., et al. (2007). The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing and Clinical Electrophysiology, 30(7), 858–864.

    Article  PubMed  Google Scholar 

Download references

Funding source

The study was supported by a grant from the Cleveland Clinic Bakken Heart Brain Institute. M. Chung has received support from NIH R01 HL111314 and R01 HL090620.

Relationships with industry

M. Chung: industry-sponsored research with Medtronic, Boston Scientific, St. Jude Medical, Biotronik. S. Sears: consultant to Medtronic; are search grants from Medtronic directed to East Carolina University; speaker honorarium from Medtronic, Boston Scientific, St Jude Medical, Biotronik; founder of QOL Apps, Inc. and inventor of ICD Coach. S. Pedersen consultant for Boston Scientific. All other authors disclose no relationships with industry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mina K. Chung.

Additional information

Mohammed Qintar and Jason J. George equal first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 15 kb)

ESM 2

(DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qintar, M., George, J.J., Panko, M. et al. A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. J Interv Card Electrophysiol 43, 65–75 (2015). https://doi.org/10.1007/s10840-015-9990-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-015-9990-7

Keywords

Navigation